Cargando…

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit

OBJECTIVE: Appropriate use of antibiotics in the management of hospitalised patients with COPD exacerbations is defined within the GOLD strategy. This paper analyses the factors associated with antibiotic prescribing in patients to better understand how prescribing may be improved. METHODS: The Euro...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Campos, Jose Luis, Hartl, Sylvia, Pozo-Rodriguez, Francisco, Roberts, C. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408103/
https://www.ncbi.nlm.nih.gov/pubmed/25905726
http://dx.doi.org/10.1371/journal.pone.0124374
_version_ 1782368019459080192
author López-Campos, Jose Luis
Hartl, Sylvia
Pozo-Rodriguez, Francisco
Roberts, C. Michael
author_facet López-Campos, Jose Luis
Hartl, Sylvia
Pozo-Rodriguez, Francisco
Roberts, C. Michael
author_sort López-Campos, Jose Luis
collection PubMed
description OBJECTIVE: Appropriate use of antibiotics in the management of hospitalised patients with COPD exacerbations is defined within the GOLD strategy. This paper analyses the factors associated with antibiotic prescribing in patients to better understand how prescribing may be improved. METHODS: The European COPD audit was a study of clinical care in 384 hospitals from 13 European countries between 2010 and 2011 enrolling 16018 patients. Those admitted to hospital due to a clinician-made diagnosis of exacerbation of COPD at the time of discharge were audited. We defined antibiotic prescribing compliance as consistent with the GOLD 2010 recommendations. Two different multivariate models were used to evaluate factors associated with the prescription of antibiotics and the guideline-compliant prescriptions. RESULTS: Overall 86% of admissions were given antibiotics but only 61.4% cases met the GOLD recommendations. Antibiotics were more likely to be given in hospital and at discharge if received prior to admission. Antibiotic prescription was more likely in patients who met the GOLD recommendations and in those with radiological consolidation but there was also a significant use of antibiotics in patients who did not meet either criterion. Patients cared for on a Respiratory Ward were more likely to receive GOLD compliant antibiotic management. CONCLUSIONS: The present study describes the audited in-hospital antibiotic prescription for COPD exacerbation across different European countries. In general, there is an apparent overuse of antibiotics likely to be associated with both patient and practice-related variables.
format Online
Article
Text
id pubmed-4408103
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44081032015-05-04 Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit López-Campos, Jose Luis Hartl, Sylvia Pozo-Rodriguez, Francisco Roberts, C. Michael PLoS One Research Article OBJECTIVE: Appropriate use of antibiotics in the management of hospitalised patients with COPD exacerbations is defined within the GOLD strategy. This paper analyses the factors associated with antibiotic prescribing in patients to better understand how prescribing may be improved. METHODS: The European COPD audit was a study of clinical care in 384 hospitals from 13 European countries between 2010 and 2011 enrolling 16018 patients. Those admitted to hospital due to a clinician-made diagnosis of exacerbation of COPD at the time of discharge were audited. We defined antibiotic prescribing compliance as consistent with the GOLD 2010 recommendations. Two different multivariate models were used to evaluate factors associated with the prescription of antibiotics and the guideline-compliant prescriptions. RESULTS: Overall 86% of admissions were given antibiotics but only 61.4% cases met the GOLD recommendations. Antibiotics were more likely to be given in hospital and at discharge if received prior to admission. Antibiotic prescription was more likely in patients who met the GOLD recommendations and in those with radiological consolidation but there was also a significant use of antibiotics in patients who did not meet either criterion. Patients cared for on a Respiratory Ward were more likely to receive GOLD compliant antibiotic management. CONCLUSIONS: The present study describes the audited in-hospital antibiotic prescription for COPD exacerbation across different European countries. In general, there is an apparent overuse of antibiotics likely to be associated with both patient and practice-related variables. Public Library of Science 2015-04-23 /pmc/articles/PMC4408103/ /pubmed/25905726 http://dx.doi.org/10.1371/journal.pone.0124374 Text en © 2015 López-Campos et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
López-Campos, Jose Luis
Hartl, Sylvia
Pozo-Rodriguez, Francisco
Roberts, C. Michael
Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
title Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
title_full Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
title_fullStr Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
title_full_unstemmed Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
title_short Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
title_sort antibiotic prescription for copd exacerbations admitted to hospital: european copd audit
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408103/
https://www.ncbi.nlm.nih.gov/pubmed/25905726
http://dx.doi.org/10.1371/journal.pone.0124374
work_keys_str_mv AT lopezcamposjoseluis antibioticprescriptionforcopdexacerbationsadmittedtohospitaleuropeancopdaudit
AT hartlsylvia antibioticprescriptionforcopdexacerbationsadmittedtohospitaleuropeancopdaudit
AT pozorodriguezfrancisco antibioticprescriptionforcopdexacerbationsadmittedtohospitaleuropeancopdaudit
AT robertscmichael antibioticprescriptionforcopdexacerbationsadmittedtohospitaleuropeancopdaudit
AT antibioticprescriptionforcopdexacerbationsadmittedtohospitaleuropeancopdaudit